Author

Jinghua Yu

Ionis Pharmaceuticals (United States)ORCID 0000-0001-8444-4327Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Armand SorianoiD· 1 shared C. Frank BennettiD· 1 shared Daniel A Norris· 1 shared Eric E. SwayzeiD· 1 shared Frank RigoiD· 1 shared Gemma BachmanniD· 1 shared John L. HunyaraiD· 1 shared Karen LingiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Armand SorianoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyNucleic Acids ResearchPeer-reviewedMay 2, 2026

Enhanced splicing modulation by NMA-modified antisense oligonucleotides

Karen Ling, Thazha P. Prakash, Jinghua Yu…·Frank Rigo

This paper introduces NMA-modified antisense oligonucleotides that show improved potency compared to MOE-modified SSOs in modulating splicing for SMA and Dravet syndrome.

6 citationstop 1%

humanmouse

𝕏 PostBluesky